Brisbane based biotech scale-up, Microbio, is set to take on new local and international markets after gaining International Organisations for Standardisation (ISO) 13485:2016 Certification for its quality management system. Read more in the media release: 221115 ISO Certification opens new markets for Microbio
Tag: diagnostic
Microbio conducts commercial evaluation trials in Ecuador
Australian biotech scale-up Microbio has started commercial evaluation trials in Ecuador prior to launching its flagship InfectID-BSI (Bloodstream Infection) test in South America. Read more in the media release: 221019 Microbio conducts commercial evaluation trials in Ecuador
Microbio receives clearance to sell InfectID-BSI in UK
Australian biotech scale-up Microbio has received clearance for the sale of its revolutionary InfectID-BSI bloodstream infection test in the United Kingdom. Read more in the media release: 220815_Microbio_receives_clearance_to_sell_in_UK
Microbio announces new status as an unlisted Public Company
Queensland’s Microbio has become an unlisted public company in a move to position the biotechnology scale-up for expansion into international markets. This move to public company status coincided with the company’s recent CE Mark of approval for the use of its revolutionary Bloodstream Infection test, Microbio InfectID-BSI in Europe. Read more in the media release:… Continue reading Microbio announces new status as an unlisted Public Company
Microbio’s bloodstream infection test cleared for sale in Europe
Australian biotech scaleup, Microbio is set to break into the European market with its flagship bloodstream infection (BSI) test. Following extensive clinical evaluation trials, the company has been granted a CE Mark, which has opened the door for distribution and use in Europe. Read more in the media release: 220614_Australian_bloodstream_infection_test_cleared_for_sale_in_Europe